comparemela.com
Home
Live Updates
TILT Biotherapeutics Announces over $10 Million Financing to Advance Oncology Immunotherapy Assets : comparemela.com
TILT Biotherapeutics Announces over $10 Million Financing to Advance Oncology Immunotherapy Assets
Appoints Tuija Keinonen as Chair TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, announces it has completed the first close of its financing
Related Keywords
Guangdong
,
Jilin
,
China
,
Helsinki
,
Eteläuomen Läi
,
Finland
,
Finnish
,
Chinese
,
Pembrolizumab Keytruda
,
Avelumab Bavencio
,
Aino Kalervo
,
Akseli Hemminki
,
Timo Ahopelto
,
Kostenloser Wertpapierhandel
,
Tuija Keinonen
,
Miia Kaye
,
University Of Helsinki
,
European Innovation Council
,
Linkedin
,
Pfizer Alliance
,
Scius Communications
,
Merck Kga
,
Tesi Finnish Industry Investment Ltd
,
Merck Kgaa
,
Appoints Tuija Keinonen
,
Lifeline Ventures
,
Finnish Industry Investment Ltd
,
Venture Founding Partner
,
Investment Manager
,
Business Finland
,
Tilt
,
Iotherapeutics
,
Nnounces
,
Dover
,
Billion
,
Financing
,
Advance
,
Ncology
,
Immunotherapy
,
Assets
,
comparemela.com © 2020. All Rights Reserved.